Mein Warenkorb

IL-10 R alpha

IL-10 R alpha Molekülinformation

Englischer NameInterleukin 10 receptorAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel9Target-AliasReceptors, Interleukin-10
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Englischer NameInterleukin 10 receptor
Target-AliasReceptors, Interleukin-10
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel9
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical

IL-10 R alpha Produktliste

  • Attribut

    Protein (4)

  • Produktbibliothek

    Online (4)

  • Spezies

    Human (2)Cynomolgus (1)Mouse (1)

  • Etikett

    Fc Tag & Avi Tag (1)Fc Tag (3)

  • Marker

    Biotin-labeled (1)Unconjugated (3)

IL-10 R alpha Molekülalias

Interleukin-10 receptor subunit alpha,IL-10 receptor subunit alpha,IL-10R subunit alpha,IL-10RA,CDw210a,Interleukin-10 receptor subunit 1,IL-10R subunit 1,IL-10R1,CD210,IL10RA,IL10R

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
IAE-0972IAE-0972Phase 3 ClinicalSunHo (China) BioPharmaceutical Co LtdCarcinoma, Basosquamous; Carcinoma, Hepatocellular; Colorectal Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
Recombinant anti-human EGFR antibody/IL-10 bispecific Fc fusion protein(Dingfu Biotarget)CmAb-(IL10)2; DF203; DF-203Phase 2 ClinicalDingfu Biotarget Co LtdAscites; Pleural Effusion, Malignant; Solid tumours
Details
AG-019AG-019Phase 2 ClinicalPrecigen Actobio IncDiabetes Mellitus, Type 1
Details
Meta 10C-IL-10 TILsMeta10-TIL; Meta 10C-IL-10 TILsPhase 2 ClinicalLeman Biotech Co LtdNeoplasms; Solid tumours
Details
IBB-0979IBB0979; IBB-0979Phase 2 ClinicalSunHo (China) BioPharmaceutical Co LtdCarcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Neoplasms; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
Details
VimekofuspAMT-101 (Applied Molecular Transport)Phase 2 ClinicalApplied Molecular TransportColitis, Ulcerative
Details
F8-IL10F8-IL10; PF-06687234Phase 2 ClinicalPhilogen SpaArthritis, Rheumatoid; Colitis, Ulcerative; Inflammatory Bowel Diseases
Details
PEG-ilodecakinAM-0010Phase 1 ClinicalArmo Biosciences, Merck Sharp & Dohme CorpBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Granulomatosis with Polyangiitis; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Vasculitis
Details
Diakine-DK2 10 (EGFR)DK210; DK-2-10Phase 1 ClinicalDeka Biosciences IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Kidney Neoplasms; Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Solid tumours
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns